Klebsiella pneumoniae Mutants Resistant to Ceftazidime-Avibactam Plus Aztreonam, Imipenem-Relebactam, Meropenem-Vaborbactam, and Cefepime-Taniborbactam
Open Access
- 19 April 2022
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 66 (4) , e0217921
Abstract
We show that a previously described Klebsiella pneumoniae variant that is resistant to ceftazidime-avibactam plus meropenem-vaborbactam, has a ramR plus ompK36 mutation, and produces the V239G variant KPC-3 (V240G per the standard numbering system) exhibits resistance to ceftazidime-avibactam plus aztreonam and imipenem-relebactam but not cefepime-taniborbactam. The V239G variant does not generate collateral β-lactam susceptibility like many KPC-3 variants associated with ceftazidime-avibactam resistance.Keywords
All Related Versions
Funding Information
- UKRI | Medical Research Council (MR/S004769/1)
This publication has 18 references indexed in Scilit:
- In vitro selection of aztreonam/avibactam resistance in dual-carbapenemase-producing Klebsiella pneumoniaeJournal of Antimicrobial Chemotherapy, 2019
- Interplay between β-lactamases and new β-lactamase inhibitorsNature Reviews Microbiology, 2019
- Effect of Porins and bla KPC Expression on Activity of Imipenem with Relebactam in Klebsiella pneumoniae : Can Antibiotic Combinations Overcome Resistance?Microbial Drug Resistance, 2018
- Prediction of Fluoroquinolone Susceptibility Directly from Whole-Genome Sequence Data by Using Liquid Chromatography-Tandem Mass Spectrometry To Identify Mutant GenotypesAntimicrobial Agents and Chemotherapy, 2018
- Envelope proteome changes driven by RamA overproduction in Klebsiella pneumoniae that enhance acquired β-lactam resistanceJournal of Antimicrobial Chemotherapy, 2017
- Impaired Inhibition by Avibactam and Resistance to the Ceftazidime-Avibactam Combination Due to the D 179 Y Substitution in the KPC-2 β-LactamaseAntimicrobial Agents and Chemotherapy, 2017
- Prediction of cephalosporin and carbapenem susceptibility in multi-drug resistant Gram-negative bacteria using liquid chromatography-tandem mass spectrometrybioRxiv, 2017
- Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae InfectionsAntimicrobial Agents and Chemotherapy, 2017
- Reduced Susceptibility to Cefepime in Clinical Isolates of Enterobacteriaceae Producing OXA-1 Beta-LactamaseMicrobial Drug Resistance, 2016
- Outbreak of Klebsiella pneumoniae Producing a New Carbapenem-Hydrolyzing Class A β-Lactamase, KPC-3, in a New York Medical CenterAntimicrobial Agents and Chemotherapy, 2004